LANTON 30

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

LANSOPRAZOLE

Disponível em:

RAFA LABORATORIES LTD

Código ATC:

A02BC03

Forma farmacêutica:

CAPSULES

Composição:

LANSOPRAZOLE 30 MG

Via de administração:

PER OS

Tipo de prescrição:

Required

Fabricado por:

LABORATORIOS LICONSA S.A., SPAIN

Grupo terapêutico:

LANSOPRAZOLE

Área terapêutica:

LANSOPRAZOLE

Indicações terapêuticas:

• Treatment of duodenal and gastric ulcer• Treatment of reflux oesophagitis• Prophylaxis of reflux oesophagitis• Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H.pylori-associated ulcers• Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment• Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy• Symptomatic gastroesophageal reflux disease• Zollinger-Ellison syndrome.

Data de autorização:

2023-10-31

Folheto informativo - Bula

1
PATIENT LEAFLET ACCORDING TO THE PHARMACISTS' REGULATIONS
(PREPARATIONS) – 1986
This medicine is sold with a doctor's prescription only
LANTON 15
LANTON 30
CAPSULES
ACTIVE INGREDIENT:
Each Lanton 15 capsule contains: Lansoprazole 15 mg
Each Lanton 30 capsule contains: Lansoprazole 30 mg
For the list of the additional ingredients, see section 6.
See also ‘Important information about some of the medicine’s
ingredients’ in section 2.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have any further questions,
please refer to your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may harm
them, even if it seems to you that their illness is similar to yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine reduces stomach acid secretion.
The medicine is intended for:
•
Treatment of gastric (stomach) ulcers and duodenum ulcers.
•
Treatment and recurrence prevention of reflux esophagitis .
•
Combined treatment with antibiotic therapy to eradicate the
Helicobacter pylori (H.Pylori)
bacteria associated with ulcers in the digestive system.
•
Treatment and prevention of ulcers in the stomach and/or the duodenum
caused as a result of
treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
•
Treatment of symptomatic Gastroesophageal Reflux Disease (GERD).
•
Treatment of Zollinger-Ellison syndrome.
THERAPEUTIC GROUP:
Proton pump inhibitors (PPIs).
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient or to any of the
additional ingredients the
medicine contains (for the list of the additional ingredients, see
section 6). Symptoms of an
allergic reaction can include: a rash, breathing and/or swallowing
problems, swelling of the
face, lips, throat or tongue.
SPECIAL WARNINGS REGARDING THE USE OF THIS MEDICINE:
BEFORE (AND DURING) TREATMENT WITH LANTON TELL YOUR DOCTOR IF:
•
You have liver problems